发明名称 |
A pharmaceutical composition for the treatment of a joint disease comprising PAK inhibitor |
摘要 |
The invention refers to the use of a p21-activated kinase (PAK) inhibitor for the treatment of a joint disease such as osteoarthritis or rheumatoid arthritis or for the treatment of a joint pain and the use of PAK as a target protein for the discovery of a PAK inhibitor as a medicament for the treatment of a joint disease. |
申请公布号 |
KR101299936(B1) |
申请公布日期 |
2013.08.26 |
申请号 |
KR20127006010 |
申请日期 |
2004.07.15 |
申请人 |
|
发明人 |
|
分类号 |
A61K38/08;A61K38/45;A61P19/02;C07K16/40;G01N33/15;G01N33/52;G01N33/53;G01N33/68 |
主分类号 |
A61K38/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|